Some consequences of assuming simple patterns for the treatment effect over time in a linear mixed model-Reference-Cited by-同舟云学术

Some consequences of assuming simple patterns for the treatment effect over time in a linear mixed model

Published:2012-12-14 Issue:15 Volume:32 Page:2585-2594
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Bamia Christina¹,White Ian R.²,Kenward Michael G.³

Affiliation:

1. Department of Hygiene, Epidemiology and Medical Statistics University of Athens, Medical School Athens Greece

2. Institute of Public Health MRC Biostatistics Unit Cambridge U.K.

3. London School of Hygiene and Tropical Medicine, Medical Statistics Unit London U.K.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.5707

Reference20 articles.

1. CarpenterJR KenwardMG.Missing data in randomised controlled trials a practical guide 2008. Published at:http://www.pcpoh.bham.ac.uk/publichealth/nccrm/PDFs_and_documents/Publications/Final_Report_RM04_JH17_mk.pdf.

2. Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design

3. Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How important is the linearity assumption in a sample size calculation for a randomised controlled trial where treatment is anticipated to affect a rate of change?;BMC Medical Research Methodology;2023-11-21

2. The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor;Cancer Medicine;2021-11-29

3. The Measurement of Treatment Effects;Statistical Issues in Drug Development;2021-06-02

4. Intention‐to‐Treat, Missing Data and Related Matters;Statistical Issues in Drug Development;2021-06-02

5. Multiplicity;Statistical Issues in Drug Development;2021-06-02